Cambridge Investment Research Advisors
ARA

Cambridge Investment Research Advisors’s American Renal Associates Holdings, Inc ARA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-41,338
Closed -$652K – 2329
2018
Q2 		$652K Buy
41,338
+1,577
+4% +$24.8K 0.01% 1253
2018
Q1 		$749K Buy
+39,761
New +$784K 0.01% 1106

Other funds holding ARA

CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WIC
Whitegate Investment Counselors Concord, New Hampshire $351M AUM 16.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cambridge Investment Research Advisors's ARA Position: Q3 2018 in Review

Cambridge Investment Research Advisors sold out of American Renal Associates Holdings, Inc (ARA) in Q3 2018, closing a stake of 41,338 shares — an estimated $652K sold.

Cambridge Investment Research Advisors first reported a position in ARA in Q1 2018 and held it in 2 quarters. The position peaked at $749K in Q1 2018. 82 funds tracked by Wall St. Rank hold ARA as of Q3 2018.

  • Cambridge Investment Research Advisors reported no remaining American Renal Associates Holdings, Inc position as of Q3 2018 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 41,338 American Renal Associates Holdings, Inc shares in Q3 2018, an estimated $652K.
  • Cambridge Investment Research Advisors first reported a position in American Renal Associates Holdings, Inc in Q1 2018 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's American Renal Associates Holdings, Inc position peaked at $749K in Q1 2018.
  • 82 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q3 2018.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2018, filed 2 Nov 2018.